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 Blood sample rejection rate in a single large NHS Foundation Trust is high.
 The highest rate of blood sample rejection is in the Accident and Emergency department.
 Blood sample rejection is associated with increased in-hospital stay.
 Blood sampling technique impacts on rejection rates.
 Reduction in sample rejection rates in emergency care areas in acute hospitals has the potential to impact on patient ﬂow and cost.a r t i c l e i n f o
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Background: Timely availability of blood sample results for interpretation affects planning and delivery
of patient care from initial assessment in Accident and Emergency (A&E) departments.
Materials and methods: Rates of, and reasons for, rejected blood samples submitted from all clinical areas
over one month were evaluated. Haemoglobin (Hb) represented haematology and potassium (Kþ),
biochemistry. A prospective observational study evaluated the methodology of sample collection and
impact on utility.
Results: 16,061 haematology and 16,209 biochemistry samples were evaluated; 1.4% (n ¼ 229, range 0.5
e7.3%) and 4.7% (n ¼ 762, range 0.9e14%) respectively were rejected, with 14% (n ¼ 248/1808) Kþ
rejection rate in A&E. Patients with rejected Kþ and Hb had a longer median in-hospital stay of 9 and 76 h
respectively and additional stay ﬁxed costs of £26,824.74 excluding treatment. The rejection rate with
Vacutainer and butterﬂy (4.0%) was lower than Vacutainer and cannula (28%).
Conclusion: Sample rejection rate is high and is associated with increased in-hospital stay and cost. Blood
sampling technique impacts on rejection rates. Reduction in sample rejection rates in emergency care
areas in acute hospitals has the potential to impact on patient ﬂow and reduce cost.
© 2017 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Over the last ten years Accident & Emergency (A&E) atten-
dances in England have increased to 16 million per year with a 31%
increase in emergency admissions and is projected to increaseeartlands Hospital, Bordesley
).
er Ltd on behalf of IJS Publishingfurther as the population ages and expands [1]. Managing the
throughput of A&E requires minimisation of delays in care provi-
sion. The timely availability of blood results is a core component of
patient assessment and decision-making. Almost all patients being
admitted through A&E have haematology and biochemistry blood
samples taken. Early diagnosis allows swift intervention, prevent-
ing patient deterioration [2]. Many risk scoring systems rely on
blood test results as one or more of their components to help
identify patients requiring urgent surgery or intensive careGroup Ltd. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. A: A funnel plot of haemoglobin rejection rate by clinical area. B: A funnel plot of
potassium rejection rate by clinical area.
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limited. Previous studies have shown that not all blood samples are
clinically indicated, nor will inﬂuencemanagement [2,4,5]. A recent
publication suggest that overdue blood tests may be an important
source of variation in spending by acute hospitals and a substantial
potential cost saving [4]. Here, we evaluated the extent and reasons
for blood sample rejection, impact on acute decision-making and
use of hospital resources.
2. Materials and methods
All Trust staff undertaking phlebotomy attend mandatory
training; the standard approach is the Vacutainer® system attached
directly to a needle or via butterﬂy tube (BD Medical, Oxford, UK).
All samples are processed in the hospital laboratory. A prospective
audit was performed over a one-month period to identify the
number of rejected blood samples using the Telepath Systems Ltd
electronic laboratory system using predeﬁned criteria. The deﬁni-
tion of a rejected sample was one that had reached the laboratory,
which could not be processed.
A rejected haemoglobin (Hb) and potassium (Kþ) level were
chosen to represent haematology and biochemistry respectively.
The origin of samples and the reason for rejection was collected.
External samples were excluded. The number of samples repeated
within 24 h, time fromnotiﬁcation of initial rejection to the repeat's
sample laboratory receipt, and length of stay of admitted patients
were collected. Fixed costs for additional length of stay for patients
with rejected samples were calculated using standard tariffs (£7.01/
hour or £168.17 a day) excluding investigative and treatment costs.
Additionally, a prospective cohort study was performed to
evaluate sampling approaches as a cause of rejection. Blood sam-
pling technique was observed in the Accident and Emergency
(A&E) department by senior nurses over a two-week period. The
identity of the blood taker, technique, cannula diameter, and any
difﬁculties encountered were documented and correlated with the
phlebotomist's sample rejection rates. The Clinical Audit Commit-
tee of University Hospitals Birmingham (UHB) approved this study.
3. Statistical analysis
Blood sample rejection rates by clinical area were analysed with
a Chi2 analysis and funnel plots to identify areas with differing test
rejection rates of two or more standard deviations. Time delays
were reported as medians and ranges, and analysed with Mann-
Whitney tests. Statistical analyses were performed using IBM
SPSS 19 (IBM SPSS Inc.) and funnel plots produced using the
Analytical Tools for Public Health template [6].
4. Results
There was a statistically signiﬁcant difference in Hb (Chi2
p ¼ 0.006) and Kþ (Chi2 p ¼ 0.001) rejection rates across clinical
areas (Fig. 1, Table 1). Rejection rates were highest for Hb and Kþ
from A&E at 1.7% and 13.7% respectively (Table 1, Fig. 1).
The main cause for Hb rejection was failure of sample to reach
the laboratory in 83 (36%) (Table 2) where an empty packet without
a sample was sent to the lab. Eight of 30 (27%) initial Hb samples
taken in A&E were not repeated. The main cause for Kþ rejection
was haemolysis in 678/762 (89%) (Table 2). Of 248 A&E rejected Kþ
samples, 99 (40%) were not repeated.
After the initial A&E sample was rejected, the time for a second,
repeat sample to reach the laboratory after the ﬁrst was processed
was 7 h (range 1e81) for Hb and 9 h (range 0e276) for Kþ samples.
In-hospital stay was increased by a median of 9 h for rejected Kþ
and 76 h for rejected Hb samples respectively (Table 3).A review of A&E records for rejected Hb samples conﬁrmed
delays in antibiotic treatment in three patients, surgery in one, and
pulmonary embolus treatment in one. The additional cost for
increased length of stay due to rejected blood test from A&E was
calculated as £16,286.20 and £10,538.54 for repeat Kþ and Hb
sampling respectively.
In the prospective part of the study, blood sampling method-
ology in A&E was observed in 163 patients. 27 (18%) of 155 Kþ
samples were rejected. 7 of 23 patients who met the criteria of
‘difﬁcult to bleed’ had rejected samples. The nursing staff bled the
majority (91/155, 59%) and a variety of methodologies were
observed (Tables 4 and 5).
The rejection rate with Vacutainer and butterﬂy (4.0%) was
lower than Vacutainer and cannula (28%) (p ¼ 0.001) (Table 5).
There was no difference in rejection rates between A&E (4.0%) and
combined ward areas (3.5%) (p ¼ 0.693) for Vacutainer and needle
or butterﬂy tube (Table 5).5. Discussion
This study conﬁrms blood sample rejection rate variation across
clinical areas with the highest in A&E. Sample rejection is often
related to problems arising prior to analysis and laboratory errors
are rare [7,8]. In this study there was no evidence of transportation
Table 1
Rejected blood samples by clinical area.
Hb Wards CCU CDU A&E
Total (range) 8955 (21e787) 1804 1260 1711
Number Rejected (% of total) 143 (1.6%) 13 (0.72%) 19 (1.51%) 30 (1.75%)
Kþ Wards CCUs CDU A&E
Total (range) 8956 (23e856) 1724 1406 1808
Number rejected (% of total) 323 (3.61%) 28 (1.62%) 97 (6.90%) 248 (13.7%)
Abbreviations: CCU, Coronary Care unit; CDU, Clinical Decision unit; A&E, Accident and Emergency.
Table 2
Causes of haemoglobin and potassium sample rejection.
Haemoglobin Potassium
Cause Number Percentage Cause Number Percentage
No sample sent 83 36.2% Haemolysed 678 89.0%
Clotted 61 26.6% Lipaemica 38 5.0%
Unlabelled 28 12.2% Unsuitable for analysis 23 3.0%
Mislabelled 18 7.9% Insufﬁcient sample sent 11 1.4%
Wrong bottle 18 7.9% Contaminatedb 5 0.7%
Insufﬁcient 18 7.9% Specimen left on cells*** 3 0.4%
Unknown reason 3 1.3% Mislaid in lab 2 0.3%
No sample with form 1 0.1%
Mislabelled 1 0.1%
Total 229 Total 762
***Samples being left too long or taken more than 8 h to reach the labs so potassium leaches out of cells.
a High lipaemic level rendering analysis not possible; not a technical fault.
b Contaminated sample, usually with preservatives from other Vacutainer bottles, used in an incorrect order of draw.
Table 3
Median inpatient hospital stay.
Median inpatient hospital stay Accepted initial sample n, median stay in hours (quartiles) Rejected initial sample n, median stay in hours (quartiles) P value
Kþ 1286 patients, 41 h (13e137) 261 patients, 50 h (18e168) 0.007
Hb 20 patients, 114 h (31e292) 1,389, 38 h (12e142) 0.018
Table 4
Potassium sample rejection rate by A&E clinician group.
Acceptability Blood taker
Nurse Junior Doctor Registrar Consultant Medical student Phlebotomist HCA Total
Haemolysed 16 5 3 0 3 0 0 27
Non haemolysed 75 31 9 2 10 0 1 128
Rejected samples (%) 18% 14% 25% 0% 23% 0% 0% 17%
^A difﬁcult patient to bleed was deﬁned as a patient with one or more of the following criteria: blood pressure less than 80/40 mmHg, two or more individuals attempting
sampling before success, four or more sampling attempts, or the need for an arterial puncture.
Table 5
Potassium rejection and acceptance rates by sampling methodology.
Technique Rejected Accepted Overall % Rejected
Cannula with syringe 1 10 11 10%
Cannula with Vacutainer 24 63 87 28%
Not Recorded 0 1 1 0%
Needle or butterﬂy with syringe 0 7 7 0%
Vacutainer with needle or butterﬂy 2 48 50 4%
Total 27 128 155 17%
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rejection was haemolysis, the ﬁndings do not support difﬁculties
obtaining samples from acutely unwell patients [9]. The specialist
renal and oncology wards typically associated with poor venous
access maintained a low rejection rate [10].We recognise the limitations of this retrospective, uncontrolled
before and after, single institution study. The ﬁndings corroborate
previous reports and the institution has similar emergency care
provision processes to other large acute NHS Trusts [9,11]. We
recognise that the outcomes could be inﬂuenced by secular trends
and confounders. It is clear that a number of aspects of patient care
cannot be disclosed including indications and experience of in-
dividuals drawing blood.
We observed low rejection rates of 3% in ward areas where
Vacutainer and butterﬂy use is standard practice. A statistically
signiﬁcant increase in Kþ rejection rate was observed in A&E with
cannula attached to Vacutainer. This is consistent with previous
publications implicating technical approach in observed variations
in quality, and the occurrence of differing approaches in A&E
[7,9,11,12]. Sample rejection resulted in a statistically signiﬁcant
increase in hospital stay and additional costs of £26,824.73/month.
D.M.S. Bodansky et al. / Annals of Medicine and Surgery 20 (2017) 37e4040We recognise a surprisingly long delay between blood draws for
patients whose blood was rejected and a high proportion of lost
samples. In England 5,581,548 patients were admitted through A&E
between 2/3/14 and 1/3/15 [13]. If the observed sample rejection
rates are experienced at other Trusts the ﬁnancial implications for
the NHS are signiﬁcant.
While the reasons cannot be clearly deﬁned, delays in
commencing appropriate treatment were observed. Repeat sam-
pling was not performed in up to 40% of rejected samples. This
ﬁnding in itself highlights the problem of inappropriate sampling
which were not necessary in patient management decisions and
represents another area for cost efﬁciencies [2,4,14,15].6. Conclusion
Reduction in sample rejection rates in emergency care areas in
acute hospitals has the potential to impact on patient ﬂow and cost.
Further work is required to evaluate if standardised use of the
Vacutainer and butterﬂy system in emergency areas results in a
reduction in sample rejection rates, with evaluation of the evidence
that this quality improvement initiative makes a difference to pa-
tient ﬂow and cost.Ethical approval
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